Measure the whole path

A quality-improvement report from OU Health documented 388 contaminated surgical-instrument-set events from July 1, 2025, through January 31, 2026. The events included bioburden, hair, holes in wrapping, debris, wet sets, filter defects, and improper disassembly.

A separate national-level survey offers a wider but less detailed signal. Its abstract says more than 90% of responding SPDs recalled at least one defect in a single week, with higher reported defects where quality-checklist or tracking-system use was inconsistent and staff certification requirements were absent. The abstract does not disclose respondent count, response rate, or sampling frame, so the finding cannot establish prevalence, causation, or a universal benchmark.

The distribution was uneven. Neurosurgery accounted for 136 events, or 36% of the total reported in the abstract. Contaminated sets were also tied to 57% of documented operating-room delays, representing 2,851 delay minutes. The authors estimated $176,762 in direct costs during the study period and projected $589,042 annually.

The project did not treat contamination as a problem owned by one room. The multidisciplinary team included administrators, surgeons, nurses, scrub technicians, sterile-processing technicians, and quality specialists. Its intervention bundle covered point-of-use cleaning, SPD protective practices, washer maintenance, wrapping and container choices, tray weight, static-attracting materials, and targeted education.

The abstract reports intermittent short-term improvement alongside persistent recurrence across contamination types. That matters because a temporarily lower count can look like resolution when the underlying failure path still spans multiple teams, materials, and handoffs.

The team used root-cause analysis, process mapping, and longitudinal tracking rather than treating every event as the same defect. A hole in wrapping, retained debris, bioburden, a wet set, a filter defect, and improper disassembly can be found at the same destination while originating in different parts of the system. A shared event record creates a place to keep those paths separate before corrective work begins.

The cost estimate deserves the same restraint as the clinical and operating data. It is the authors’ estimate for this center and period, not a general cost-per-event benchmark. Its value is that the team connected contamination records to time and cost instead of leaving the event count isolated from operating consequences.

This is a single-center quality-improvement report. It does not establish a universal contamination rate, prove that one intervention caused the observed changes, or supply a protocol for other facilities. The useful signal is narrower: the team built a shared event definition, tracked the problem longitudinally, and connected defects to delay and cost data.

For local review, the question is whether a contaminated set can be followed across the full path. That includes where it was detected, the contamination type, the service line, the effect on the case, and the corrective work that followed. A department-only count can miss the handoffs that created the event or the downstream delay.

On June 5, the FDA posted a Class 2 recall record for the SporeTraq Mail-In Spore Testing Service after an incorrect incubation process. The FDA action text says the laboratory testing-service error affected customers using dry-heat, Chemiclave, and ethylene-oxide autoclave types and may affect the validity of the sterilization process followed at customer locations.

Separately, four FDA records posted March 20 cover the Olympus OER-Elite, OER-Pro, MAJ-1443 suction valve, and MAJ-1444 air/water valve. Those records say the two valves are no longer reprocessing-compatible with the two reprocessors.

All records were open and classified when checked on August 10. This brief does not interpret biological-indicator results or replace the current FDA notices, manufacturer communication, or facility recall process.

HSPA says new Certified Healthcare Leader eligibility requirements begin with the October 2026 pilot exam.

Applicants must hold a current CRCST and meet one of three paths: 2,080 hours of sterile-processing experience, 2,080 hours in a qualifying leadership role, or an associate degree or higher.

Pilot applications are due September 15, and the test window is October 1–15. HSPA asks applicants to allow three to four weeks for processing. Current CHL holders have a separate attestation and documentation deadline before October 2027.

AAMI’s June 16 eXchange recap frames sterile-processing reliability as a shared concern for SPD, healthcare technology management, infection prevention, and facilities.

The session was led by Delores O’Connell, a former SPD manager who now works as a STERIS clinical educator.

The useful operating signal is the need for defined communication when equipment is serviced or environmental conditions drift. Technical claims from the session are excluded here unless they can be checked against primary standards, current manufacturer instructions, and facility policy.

HSPA’s new 2026 Educator Development Webinar Series runs monthly from July through December.

The next listed session is August 13 and covers teaching principles; later sessions address lesson planning, teaching tools, staff education, and continuing education.

Each event is live, with a recording available afterward. HSPA lists six continuing-education credits for completing the series and current prices of $79 for members and $150 for nonmembers. This is an HSPA educational offering, not a facility requirement or endorsement by the Brief.

A single-hospital before/after study in China applied failure mode and effects analysis to low-temperature hydrogen peroxide plasma sterilizer operations.

The researchers compared 1,551 cycles from May through November 2024 with 1,492 cycles from January through June 2025 and reported interruption rates of 5.48% and 0.87%, respectively.

The study is useful as a measurement example, but its design cannot establish general effectiveness across facilities, equipment, or workflows. This brief reports the result without recommending the study’s operating procedure.